ACRO Testifies Before FDA on Clinical Trial Modernization WASHINGTON–(BUSINESS WIRE)– The Association of Clinical Research Organizations (ACRO) today provided the FDA with a nu
Future of medicine – the critical path forward I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This
House Energy and Commerce Committee Hearing C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hear
European Medicines Agency Deems Imaging Biomarker a Qualified Measure to Select Patients with Early Stages of Cognitive Impairment for Alzheimer’s Disease Clinical Trials Based on a request for regulatory review by Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD), the
Critical Path Institute Gathers Cross-Sector Innovators at Global Conference on Drug Development Hundreds of leaders from cross-sector arenas in government, academia, the biotechnology and pharmaceutical industry, and patient a
Brian Harvey, VP, U.S. Regulatory Policy at Sanofi, speaks on panel at Partnering for Cures Nov. 8, 2011 Highlights benefits of public-private partnerships like C-Path’s Coalition Against Major Diseases (CAMD): Stresses importanc
C-Path’s Avilés Discusses Importance of Data Standards in FDA Week Article FDA is encouraging industry to use newly crafted therapeutic data standards — such as utilization of qualified biomarkers
July 5, 2011 The PRO Consortium: An FDA-Endorsed Process for PRO Instrument Development in GI Disorders and Beyond
